ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma

Evangeline R Jackson, Ryan J Duchatel, Dilana E Staudt, Mika L Persson, Abdul Mannan, Sridevi Yadavilli, Sarah Parackal, Shaye Game, Wai Chin Chong, W Samantha Nilanthi Jayasekara, Marion Le Grand, Padraic S Kearney, Alicia M Douglas, Izac J Findlay, Zacary P Germon, Holly P McEwen, Tyrone S Beitaki, Adjanie Patabendige, David A Skerrett-Byrne, Brett NixonNathan D Smith, Bryan Day, Neevika Manoharan, Sumanth Nagabushan, Jordan R Hansford, Dinisha Govender, Geoffrey B McCowage, Ron Firestein, Meegan Howlett, Raelene Endersby, Nicholas G Gottardo, Frank Alvaro, Sebastian M Waszak, Martin R Larsen, Yolanda Colino-Sanguino, Fatima Valdés-Mora, Andria Rakotomalala, Samuel Meignan, Eddy Pasquier, Nicolas Andre, Esther Hulleman, David D Eisenstat, Nicholas A Vitanza, Javad Nazarian, Carl Koschmann, Sabine Mueller, Jason E Cain, Matthew D Dun

Research output: Contribution to journalArticle (journal)peer-review

9 Citations (Scopus)
2 Downloads (Pure)

Fingerprint

Dive into the research topics of 'ONC201 in combination with paxalisib for the treatment of H3K27-altered diffuse midline glioma'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science